Clinical trials
Observational Fragile X Syndrome trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2 |
| Seaside Therapeutics, Inc. | 2 |
| Bionano Genomics | 1 |
| Esoterix Genetic Laboratories, LLC | 1 |
| Healing Hope International | 1 |
| National Institute of Mental Health (NIMH) | 1 |
| Nova Mentis Life Science Corp | 1 |
| ProgenaBiome | 1 |
| RTI International | 1 |
| University of California, Davis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fragile X Syndrome | 13 |
| Autism Spectrum Disorder | 6 |
| Developmental Disabilities | 2 |
| Down Syndrome | 2 |
| Genetic Diseases, Inborn | 2 |
| Akinetic Mutism | 1 |
| Anemia, Sickle Cell | 1 |
| Angelman Syndrome | 1 |
| Antisocial Personality Disorder | 1 |
| Anxiety Disorders | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.